• circRNA derived from CLSPN (circCLSPN) is an oncogene in human glioblastoma multiforme by regulating cell growth, migration and invasion via ceRNA pathway

    • Fulltext


        Click here to view fulltext PDF

      Permanent link:

    • Keywords


      CircCLSPN; miR-370-3p; USP39; GBM

    • Abstract


      Glioblastoma multiforme (GBM) is the most aggressive and prevalent brain tumor in adults. The circRNAderived from CLSPN (hsa_circ_0011591, circCLSPN) is remarkably upregulated in GBM; however itsfunctional role was uncovered yet. First, we examined expression of circCLSPN using GSE109569 databaseand RT-qPCR, and circCLSPN level was upregulated in human GBM tumor tissues and cells (A172 andLN18); moreover, circCLSPN showed a stable structure stability. Then, a series of loss-of-functional experimentswere performed using CCK-8 assay, colony formation assay, flow cytometry, scratch wound assay, andtranswell assay. Consequently, circCLSPN silencing suppressed cell viability, colony formation ability, cellcycle progression, migration, and invasion of A172 and LN18 cells in vitro, and promoted apoptosis rate.Allied with those were decreased B cell lymphoma-2 (Bcl-2), matrix metalloproteinase-2 (MMP2) and MMP9expression, and elevated Bcl-2-associated X protein (Bax) level. According to dual-luciferase reporter assayand RNA pull-down assay, miR-370-3p was identified to be targeted and sponged by circCLSPN, and furthertargeted and negatively regulated USP39. Functionally, overexpressing miR-370-3p could mimic in vitroeffects of circCLSPN interference. Rescue experiments revealed that blocking miR-370-3p could partiallyreverse the suppression of circCLSPN knockdown on cell growth, migration and invasion, and role of miR-370-3p overexpression was abrogated by restoring USP39. In vivo, circCLSPN knockdown hindered tumorgrowth of LN18 cells by affecting miR-370-3p, USP39, MMP2 and MMP9 expression. In conclusion,circCLSPN elicited an oncogenic role in tumorigenesis and malignant progression of human GBM cellsthrough circCLSPN-miR-370-3p-USP39 pathway.

    • Author Affiliations



      1. Department of Neurosurgery, Renmin Hospital of Wuhan Caidian District, Wuhan, Hubei, China
      2. Department of Neurosurgery, Hanyang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China
      3. Department of Oncology, The Central Hospital of Huangshi, Huangshi, Hubei, China
    • Dates

  • Journal of Biosciences | News

    • Editorial Note on Continuous Article Publication

      Posted on July 25, 2019

      Click here for Editorial Note on CAP Mode

© 2021-2022 Indian Academy of Sciences, Bengaluru.